AZD5582 is an antagonist of inhibitor of apoptosis proteins (IAPs) that targets the BIR3 domains of cIAP1, cIAP2, and XIAP. Its structural properties facilitate its binding to these domains, promoting apoptotic pathways.
Usually ships within 24 hours.